Media coverage

A Journey: Biotech, FDA, and Safety Committee Responses to COVID

Media coverage / By jpolicano

Dr. Hebbar of CalciMedica Talks Auxora Clinical Trial Targeting COVID-19, CRAC, and More| Podcast S2 E36

Media coverage / By jpolicano

Companies To Watch: CalciMedica

Media coverage / By jpolicano

Dozens of Houston’s sickest COVID-19 patients picked for trial of new drug that could reduce need for ventilator by 50 percent

Media coverage / By jpolicano

FDA greenlights expansion of COVID-19 study to VCU Medical Center after positive data

Media coverage / By jpolicano

VC Daily: Biotech Startups Ramp Up Funding and Fight Against Coronavirus; Companies Face New Privacy Ruling

Media coverage / By jpolicano

CalciMedica’s Auxora Shows Promise As COVID-19 Treatment, Patients Recovered Twice As Fast

Media coverage / By jpolicano

San Diego biotech’s drug shows early promise in treating COVID-19 pneumonia

Media coverage / By jpolicano

A drug for COVID-19 breathing problems, tested in Minnesota, shows promise

Media coverage / By jpolicano

Interim analysis indicates Auxora™ is effective in severe COVID-19 pneumonia patients

Media coverage / By jpolicano